BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2116946)

  • 1. Metabolic effects of an insulin-like factor causing hypoglycaemia in a patient with a haemangiopericytoma.
    Benn JJ; Firth RG; Sönksen PH
    Clin Endocrinol (Oxf); 1990 Jun; 32(6):769-80. PubMed ID: 2116946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma.
    Chung J; Henry RR
    J Clin Endocrinol Metab; 1996 Mar; 81(3):919-25. PubMed ID: 8772551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma.
    Hoekman K; van Doorn J; Gloudemans T; Maassen JA; Schuller AG; Pinedo HM
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):247-53. PubMed ID: 10468998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal and insulin stimulated substrate metabolism in tumour induced hypoglycaemia; evidence for increased muscle glucose uptake.
    Møller N; Blum WF; Mengel A; Hansen LB; Alberti KG; Schmitz O
    Diabetologia; 1991 Jan; 34(1):17-20. PubMed ID: 1647334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of endogenous insulin secretion regulates the rapid rise of insulin-like growth factor binding protein (IGFBP)-1 levels following acute hypoglycaemia.
    Cotterill AM; Holly JM; Amiel S; Wass JA
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):633-9. PubMed ID: 7687525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis.
    Fanelli CG; De Feo P; Porcellati F; Perriello G; Torlone E; Santeusanio F; Brunetti P; Bolli GB
    J Clin Invest; 1992 Jun; 89(6):2005-13. PubMed ID: 1602007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin-like growth factors and their binding proteins in a case of non-islet-cell tumour-associated hypoglycaemia.
    Cotterill AM; Holly JM; Davies SC; Coulson VJ; Price PA; Wass JA
    J Endocrinol; 1991 Nov; 131(2):303-11. PubMed ID: 1720806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-molecular weight IGF-2 expression in a haemangiopericytoma associated with hypoglycaemia.
    Höög A; Sandberg Nordqvist AC; Hulting AL; Falkmer UG
    APMIS; 1997 Jun; 105(6):469-82. PubMed ID: 9236865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor 1 in patients with hypoglycaemia.
    Labib M; Teale D; Marks V
    Ann Clin Biochem; 1990 Mar; 27 ( Pt 2)():107-9. PubMed ID: 2183688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor family in malignant haemangiopericytomas: the expression and role of insulin-like growth factor I receptor.
    Pavelić K; Pavelić ZP; Cabrijan T; Karner I; Samarzija M; Stambrook PJ
    J Pathol; 1999 May; 188(1):69-75. PubMed ID: 10398143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of the pancreatic beta cell response to a meal following hypoglycaemia in man.
    Frier BM; Corrall RJ; Ashby JP; Baird JD
    Diabetologia; 1980 Apr; 18(4):297-300. PubMed ID: 6998801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of insulin-induced hypoglycaemia on lipolysis rate, lipid oxidation and adipose tissue signalling in human volunteers: a randomised clinical study.
    Voss TS; Vendelbo MH; Kampmann U; Pedersen SB; Nielsen TS; Johannsen M; Svart MV; Jessen N; Møller N
    Diabetologia; 2017 Jan; 60(1):143-152. PubMed ID: 27734104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic and regional tumour metabolism in a patient with non-islet cell tumour hypoglycaemia: role of increased levels of free insulin-like growth factors.
    Møller N; Frystyk J; Skjaerbaek C; Pedersen HB; Christensen C; Schmitz O; Gee A; Gjedde A; Zapf J; Orskov H
    Diabetologia; 1996 Dec; 39(12):1534-5. PubMed ID: 8960839
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged insulin resistance following insulin-induced hypoglycaemia.
    Clore JN; Brennan JR; Gebhart SP; Newsome HH; Nestler JE; Blackard WG
    Diabetologia; 1987 Nov; 30(11):851-8. PubMed ID: 3328721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of extracellular and net glucose oxidation measured isotopically and by indirect calorimetry during high and low glucose turnover.
    McMahon MM; Marsh HM; Rizza RA
    Am J Clin Nutr; 1991 May; 53(5):1138-42. PubMed ID: 1902346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects.
    Lerche S; Soendergaard L; Rungby J; Moeller N; Holst JJ; Schmitz OE; Brock B
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):500-6. PubMed ID: 19094067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-islet-cell tumour hypoglycaemia (NICTH): About a series of 6 cases.
    Jannin A; Espiard S; Benomar K; Do Cao C; Mycinski B; Porte H; D'Herbomez M; Penel N; Vantyghem MC
    Ann Endocrinol (Paris); 2019 Feb; 80(1):21-25. PubMed ID: 29555080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin-like growth factor-II secreting prostate tumour causing severe hypoglycaemi].
    Vadász J; Barta G; Krasznai G; Ludger F; Zalatnai A
    Orv Hetil; 2014 Aug; 155(33):1319-24. PubMed ID: 25109918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The riddle of tumour hypoglycaemia revisited.
    Kahn CR
    Clin Endocrinol Metab; 1980 Jul; 9(2):335-60. PubMed ID: 6994945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypoglycemia associated with the production of insulin-like growth factor (IGF)-II by a hemangiopericytoma].
    Plikat K; Reichle A; Elmlinger MW; Schölmerich J
    Dtsch Med Wochenschr; 2003 Feb; 128(6):257-60. PubMed ID: 12571793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.